The University of Chicago Header Logo

Connection

Christopher Shea to Melanocytes

This is a "connection" page, showing publications Christopher Shea has written about Melanocytes.
Connection Strength

2.749
  1. Melanocytic tumors with intraepidermal melanophages: a report of five cases with review of 231 archived cutaneous melanocytic tumors. J Cutan Pathol. 2015 Jun; 42(6):394-9.
    View in: PubMed
    Score: 0.512
  2. Melanocytes, melanocyte stem cells, and melanoma stem cells. Clin Dermatol. 2013 Mar-Apr; 31(2):166-78.
    View in: PubMed
    Score: 0.444
  3. Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol. 2008 Nov; 35 Suppl 2:1-10.
    View in: PubMed
    Score: 0.329
  4. Recent developments in the pathology of melanocytic neoplasia. Dermatol Clin. 1999 Jul; 17(3):615-30, ix.
    View in: PubMed
    Score: 0.172
  5. Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol. 1999 May; 30(5):500-5.
    View in: PubMed
    Score: 0.170
  6. The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol. 1998 Aug; 111(2):233-8.
    View in: PubMed
    Score: 0.161
  7. Numbers and differentiation status of melanocytes in idiopathic guttate hypomelanosis. J Cutan Pathol. 1998 Aug; 25(7):375-9.
    View in: PubMed
    Score: 0.161
  8. Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases. Am J Dermatopathol. 2016 Jul; 38(7):499-503.
    View in: PubMed
    Score: 0.140
  9. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group. J Am Acad Dermatol. 2016 Aug; 75(2):356-63.
    View in: PubMed
    Score: 0.139
  10. KIT expression reveals a population of precursor melanocytes in human skin. J Invest Dermatol. 1996 May; 106(5):967-71.
    View in: PubMed
    Score: 0.138
  11. Diameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: a case-control study. J Am Acad Dermatol. 2014 Dec; 71(6):1257-1258.e4.
    View in: PubMed
    Score: 0.125
  12. Pagetoid melanocytosis: when is it significant? Pathology. 2004 Oct; 36(5):435-44.
    View in: PubMed
    Score: 0.062
  13. Maturing papillomatous nevoid melanoma in the scalp mimicking recurrent melanocytic nevus: A case report of previously undescribed subtype of nevoid melanoma. Pathol Int. 2022 Jan; 72(1):59-64.
    View in: PubMed
    Score: 0.050
  14. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol. 2001 Sep; 28(8):400-6.
    View in: PubMed
    Score: 0.050
  15. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 1995 Jul 01; 55(13):2713-8.
    View in: PubMed
    Score: 0.033
  16. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. J Cutan Pathol. 2015 Apr; 42(4):244-52.
    View in: PubMed
    Score: 0.032
  17. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Mod Pathol. 2006 Sep; 19(9):1255-60.
    View in: PubMed
    Score: 0.017
  18. p53 expression is rare in cutaneous melanomas. Am J Dermatopathol. 1995 Aug; 17(4):344-9.
    View in: PubMed
    Score: 0.008
  19. Visible action spectrum for melanin-specific selective photothermolysis. Lasers Surg Med. 1989; 9(4):389-97.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.